Joint Formulary & PAD

Nabilone - Nausea and vomiting (chemotherapy induced)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

PAD Profile

ChemicalSubstance :
Nabilone
Indication :
Nausea and vomiting (chemotherapy induced)
Group Name :
Keywords :
cannabis-based medicinal products
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
5

Other Indications

Below are listed other indications that Nabilone is used to treat.

  • No records returned.

Committee Recommendations (2)

Nabilone is not on any local Trust formulary and has been awarded a non-formulary status for this indication.

The Surrey & North West Sussex Area Prescribing Committee (APC) recommends Nabilone for chemotherapy induced nausea & vomiting in adult patients and it will be considered RED on the traffic light system. 

Providers (NHS and non-NHS) will be solely liable for clinical governance, prescribing responsibility and costs of all prescriptions of nabilone when it is used off-label i.e. outside of its marketing authorisation. Shared care will not be supported for an off-label use of nabilone.

Primary care prescribers should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.